CA2361580A1 - Thiazoloindolinone compounds - Google Patents

Thiazoloindolinone compounds Download PDF

Info

Publication number
CA2361580A1
CA2361580A1 CA002361580A CA2361580A CA2361580A1 CA 2361580 A1 CA2361580 A1 CA 2361580A1 CA 002361580 A CA002361580 A CA 002361580A CA 2361580 A CA2361580 A CA 2361580A CA 2361580 A1 CA2361580 A1 CA 2361580A1
Authority
CA
Canada
Prior art keywords
compound
thiazolindolinone
methyl
indol
thiazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002361580A
Other languages
English (en)
French (fr)
Inventor
Ambrish Vyas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2361580A1 publication Critical patent/CA2361580A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
CA002361580A 1999-03-04 2000-03-01 Thiazoloindolinone compounds Abandoned CA2361580A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9904930.6 1999-03-04
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds
PCT/US2000/005192 WO2000052013A2 (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Publications (1)

Publication Number Publication Date
CA2361580A1 true CA2361580A1 (en) 2000-09-08

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002361580A Abandoned CA2361580A1 (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Country Status (18)

Country Link
EP (1) EP1159280A2 (zh)
JP (1) JP2003532620A (zh)
KR (1) KR20020005606A (zh)
CN (1) CN1355807A (zh)
AU (1) AU3611000A (zh)
BR (1) BR0008677A (zh)
CA (1) CA2361580A1 (zh)
CZ (1) CZ20013187A3 (zh)
GB (1) GB9904930D0 (zh)
HK (1) HK1041692A1 (zh)
HU (1) HUP0200376A3 (zh)
IL (1) IL144808A0 (zh)
MX (1) MXPA01008910A (zh)
NO (1) NO20014262L (zh)
PL (1) PL351476A1 (zh)
TR (1) TR200102557T2 (zh)
WO (1) WO2000052013A2 (zh)
ZA (1) ZA200106826B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO2006060616A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Processes for producing crystalline macrolides
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および/または治療剤
EP2554184B1 (en) 2010-03-31 2016-10-26 ONO Pharmaceutical Co., Ltd. Preventive and/or remedy for hand and foot syndrome
TW201927292A (zh) 2017-12-13 2019-07-16 大陸商上海小午醫藥科技有限公司 一種用於預防或治療與egfr被抑制相關疾病的方法
CN113975264A (zh) 2018-04-16 2022-01-28 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984930B1 (en) * 1997-05-07 2005-04-06 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
HUP0200376A2 (en) 2002-06-29
NO20014262D0 (no) 2001-09-03
CZ20013187A3 (cs) 2002-02-13
WO2000052013A3 (en) 2000-12-28
MXPA01008910A (es) 2002-03-27
BR0008677A (pt) 2002-01-08
HK1041692A1 (zh) 2002-07-19
HUP0200376A3 (en) 2003-07-28
PL351476A1 (en) 2003-04-22
CN1355807A (zh) 2002-06-26
AU3611000A (en) 2000-09-21
IL144808A0 (en) 2002-06-30
TR200102557T2 (tr) 2007-01-22
EP1159280A2 (en) 2001-12-05
NO20014262L (no) 2001-10-30
KR20020005606A (ko) 2002-01-17
WO2000052013A2 (en) 2000-09-08
ZA200106826B (en) 2003-02-25
GB9904930D0 (en) 1999-04-28
JP2003532620A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
ES2199156T3 (es) Derivados de aza-oxindol sustituidos.
WO2017076346A1 (zh) 作为tlr7激动剂的7-(噻唑-5-基)吡咯并嘧啶化合物
EP1732920B1 (en) Thiophene derivatives as chk 1 inhibitors
CN108368089A (zh) 新化合物
CZ139097A3 (cs) 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi
US6624171B1 (en) Substituted aza-oxindole derivatives
JP6797923B2 (ja) Alkおよびsrpk阻害剤ならびに使用方法
EP3441389B1 (en) Pyrazole-oxazolidinone compound for anti-hepatitis b virus
CA2832483A1 (en) Methods and compositions for treating neurodegenerative diseases
CA2674875A1 (en) Purine derivatives
KR20190104632A (ko) 트라이사이클릭 자이라제 억제제
PT1246623E (pt) Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações
CN107163044B (zh) 一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
EP1325009B1 (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
CZ20032287A3 (cs) Způsoby léčení zánětlivých a imunitních nemocí za použití inhibitorů IkB kinázy (IKK)
KR20010006509A (ko) 5,7-이치환된 4-아미노피리도[2,3-d]피리미딘 화합물 및 아데노신 키나제 억제제로서의 이의 용도
HU197749B (en) Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient
CA2361580A1 (en) Thiazoloindolinone compounds
US6492398B1 (en) Thiazoloindolinone compounds
WO2018059533A1 (zh) p38αMAPK激酶抑制剂及其制备方法和应用
KR20040101564A (ko) 1-치환-1,2,3-트리아졸 유도체, 그 중간체, 및 이들의제조 방법
PL165413B1 (pl) Sposób wytwarzania nowych pochodnych 6-arylo-5,6-dwuhydroimidazo [2,1-b] tiazolu PL PL
WO2015110092A1 (zh) 4-取代吡咯并[2,3-d]嘧啶化合物及其用途
CN113004305A (zh) 大环化合物及其制备方法和用途
CN113549065B (zh) 作为JAK抑制剂的吡咯并[2,3-b]吡啶衍生物

Legal Events

Date Code Title Description
FZDE Discontinued